| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00007890-199006000-00025 |
| P698 | PubMed publication ID | 2360255 |
| P50 | author | Anna Linda Zignego | Q39507303 |
| P2093 | author name string | C Brechot | |
| P Tiollais | |||
| H Bismuth | |||
| D Samuel | |||
| M Reynes | |||
| C Féray | |||
| A Bismuth | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| liver transplantation | Q1368191 | ||
| P304 | page(s) | 1155-1158 | |
| P577 | publication date | 1990-06-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model | |
| P478 | volume | 49 |
| Q43049364 | "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease |
| Q40495828 | 'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection. European Concerted Action on Viral Hepatitis. |
| Q26775638 | Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection |
| Q40644267 | Clinical factors affecting rejection rates in liver transplantation. |
| Q40870879 | Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier |
| Q44035973 | Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation |
| Q33607528 | Controversies in patient selection for liver transplantation |
| Q45764192 | De novo and apparent de novo hepatitis B virus infection after liver transplantation. |
| Q41727379 | De novo hepatitis B infection after liver transplantation: Source of disease, incidence, and impact |
| Q28548313 | Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals |
| Q73130886 | Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection |
| Q35110095 | Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature |
| Q43046937 | HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis |
| Q77329335 | HBV viral load within subpopulations of peripheral blood mononuclear cells in HBV infection using limiting dilution PCR |
| Q34426421 | Hepatitis B and C in the liver transplant recipient: Current understanding and treatment |
| Q35543573 | Hepatitis B immune globulin preparations and use in liver transplantation |
| Q40780181 | Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. |
| Q45768676 | Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis |
| Q42581069 | Hepatitis B virus infection and liver transplantation |
| Q36348673 | Hepatitis B virus infection in liver transplant candidates and recipients. |
| Q45760926 | High-titered anti-HBs fresh frozen plasma for immunoprophylaxis against hepatitis B virus recurrence after liver transplantation |
| Q45258067 | Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients |
| Q39602141 | In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus |
| Q71738464 | Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis |
| Q45749995 | Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis |
| Q41623008 | Liver transplantation for hepatitis B virus infection |
| Q35621731 | Liver transplantation for hepatitis B virus-related liver disease: indications, prevention of recurrence and results. |
| Q72349273 | Liver transplantation for hepatocellular carcinoma |
| Q70128712 | Liver transplantation for patients with hepatitis B: what have we learned from our results? |
| Q77632455 | Liver transplantation in HBsAg+ patients: results according to patient selection and treatment strategies |
| Q70756287 | Liver transplantation in chronic viral B and C hepatitis |
| Q72511204 | Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis |
| Q45746440 | Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation. |
| Q24529103 | Management of HBV Infection in Liver Transplantation Patients |
| Q55653769 | Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran. |
| Q34080966 | Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. |
| Q91973746 | Myth: Liver Transplant Provides a Cure for Liver Disease |
| Q45767708 | PCR analysis of hepatitis B virus DNA in paraffin-embedded liver tissue from patients with chronic liver disease |
| Q68295742 | Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients |
| Q40915918 | Polymerase chain reaction for the diagnosis of hepatitis B and C viral hepatitis |
| Q27472983 | Polymerase chain reaction for the diagnosis of viral hepatitis B and C. |
| Q67485793 | Possible transplacental transmission of human papillomaviruses |
| Q46466475 | Prevention and treatment of hepatitis B virus infection after liver transplantation |
| Q58865457 | Prevention of HBV recurrence after liver transplant: The role of combination therapy |
| Q35076630 | Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era. |
| Q36886518 | Prophylaxis of hepatitis B infection in solid organ transplant recipients |
| Q35217836 | Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection |
| Q43672283 | Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. |
| Q34396583 | Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation |
| Q35601328 | Reinfection of liver graft by hepatitis C virus after liver transplantation |
| Q39979840 | Repeated passage of wild-type woodchuck hepatitis virus in lymphoid cells does not generate cell type-specific variants or alter virus infectivity |
| Q40461261 | Role of RNA secondary structure in emergence of compartment specific hepatitis B virus immune escape variants. |
| Q45759883 | Sanctuary of hepatitis B virus in bone-marrow cells of patients undergoing liver transplantation |
| Q45760963 | Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA |
| Q36542659 | Study of the Association of Mutant HBsAg Gene and Hodgkin and Non-Hodgkin Lymphoma |
| Q44973263 | Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation |
| Q42276993 | Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression |
| Q37995199 | The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review |
| Q57782645 | The course of hepatitis C virus infection after liver transplantation |
| Q44451384 | Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation? |
| Q39880293 | Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. |
| Q73747937 | Vaccines for transplant recipients |
| Q34375675 | Viral markers in the treatment of hepatitis B and C |
Search more.